Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market Report 2026

Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market Overview

• Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) market size has reached to $1.83 billion in 2025 • Expected to grow to $3.74 billion in 2030 at a compound annual growth rate (CAGR) of 15.4% • Growth Driver: Growing Acceptance Of Telemedicine And Remote Patient Monitoring Fueling The Growth Of The Market Due To Rising Digital Health Adoption • Market Trend: Artificial Intelligence (AI)-Enabled Reporting Technology Enhances Data Analysis And Decision-Making In Clinical Trials • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market?

Electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) refers to the use of AI techniques to collect, process, and interpret patient-reported data captured digitally such as symptoms, treatment experiences, quality of life, or medication adherence. AI enhances ePRO systems by identifying patterns, predicting health risks, personalizing interventions, and generating actionable insights for clinicians, researchers, and care teams. This approach improves data accuracy, enables earlier detection of issues, supports clinical decision-making, and strengthens patient engagement in healthcare and clinical trials. The main components of electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) are software, hardware, and services. Electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) software refers to digital platforms that collect patient-reported data such as symptoms, side effects, treatment responses, and quality-of-life measures and use AI algorithms to analyze and interpret that information. The solution is deployed through on-premises and cloud modes, allowing flexible data management. It finds applications in clinical trials, patient monitoring, and other healthcare processes, serving end users such as pharmaceutical companies, contract research organizations, hospitals and clinics, academic and research institutes, and other healthcare entities.

What Is The Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market Growth Forecast?

The electronic patient-reported outcomes (epro) analytics with artificial intelligence (ai) market size is expected to see rapid growth in the next few years. It will grow to $3.74 billion in 2030 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to increasing integration of ai in clinical research analytics, rising demand for continuous patient monitoring, expansion of decentralized clinical trials, growing adoption of cloud-based analytics platforms, increasing focus on proactive care interventions. Major trends in the forecast period include increasing adoption of AI-driven symptom pattern recognition, growing use of predictive analytics in patient monitoring, expansion of remote patient engagement platforms, rising integration with clinical trial management systems, enhanced focus on personalized outcome insights.

Global Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market Segmentation

1) By Component: Software, Hardware, Services 2) By Application: Clinical Trials, Patient Monitoring, Other Applications 3) By Deployment Mode: On-Premises, Cloud 4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Hospitals and Clinics, Academic and Research Institutes, Other End-Users Subsegments: 1) By Software: Data Integration And Management Tools, Artificial Intelligence And Machine Learning Algorithms, Reporting And Visualization Platforms, Mobile And Web Applications, Data Security And Compliance Solutions 2) By Hardware: Smartphones And Tablets, Wearable Health Devices, Patient Monitoring Sensors, Data Storage Servers, Networking And Connectivity Devices 3) By Services: Implementation And Integration Services, Consulting And Strategy Services, Training And Support Services, Data Analytics And Reporting Services, Maintenance And Upgradation Services

What Is The Driver Of The Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market?

The growing acceptance of telemedicine and remote patient monitoring is expected to propel the growth of the electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market going forward. Telemedicine refers to the delivery of healthcare services through digital communication technologies, while remote patient monitoring refers to the continuous collection and analysis of patients’ health data using connected devices and sensors. The rising utilization of telemedicine and remote monitoring is driven by the demand for accessible, convenient, and timely care. Increasing dependence on digital health platforms has accelerated the adoption of advanced tools that support real-time patient data capture and automated insight generation in clinical research. This trend directly supports the expansion of the Electronic Patient-Reported Outcomes (ePRO) analytics with artificial intelligence (AI) market by enabling continuous, high-quality data collection and intelligent analysis capabilities. For instance, in December 2023, the UK’s National Health Service reported that monthly digital interactions continued to increase significantly, with 33.6 million app users and a 54% rise in monthly logins over the prior year, indicating broader acceptance of digital healthcare engagement. Therefore, growing acceptance of telemedicine and remote patient monitoring is driving the growth of the electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) industry.

Key Players In The Global Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

Major companies operating in the electronic patient-reported outcomes (epro) analytics with artificial intelligence (AI) market are Oracle Health Sciences, IQVIA Inc., Parexel International Corporation, Veeva Systems Inc., Elekta AB, Kaiku Health, Clario Inc., Medidata Solutions Inc., Signant Health, eClinical Solutions LLC, Medable Inc., YPrime LLC, Kayentis SAS, uMotif Limited, Clinical Ink Inc., Curebase Inc., AiCure LLC, Climedo Health GmbH, Datacubed Health Inc., OpenClinica LLC, Castor EDC BV

Global Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market Trends and Insights

Major companies operating in the electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market are developing innovative products such as artificial intelligence (AI)-enabled reporting to enhance data accuracy, accelerate clinical insights, and streamline decision-making in clinical trials. Artificial intelligence (AI)-enabled reporting refers to the use of artificial intelligence to automatically analyze, interpret, and visualize complex data, providing faster and more accurate insights for decision-making. For instance, in January 2025, Medrio, a US-based clinical-trial technology provider offering electronic case report forms/electronic data capture (CRF/EDC), electronic clinical outcome assessment (eCOA)/electronic patient-reported outcomes (ePRO), eConsent, and randomization and trial supply management (RTSM) solutions, launched AI-enabled reporting, an innovative new capability available within the Medrio clinical data management system/electronic data capture (CDMS/EDC). It is designed to simplify data exploration for study teams overwhelmed by large volumes of clinical trial data. Embedded inside the core electronic data capture/clinical data management system (EDC/CDMS) platform (so it reduces the need for separate reporting tools). Early adopter program with sponsors and CROs guiding feature development, ensuring relevance to real-world trial workflows.

What Are Latest Mergers And Acquisitions In The Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market?

In May 2024, Eli Lilly and Company, a US-based global pharmaceutical company specializing in the discovery, development, manufacturing, and marketing of pharmaceutical products for human health, acquired Aparito Limited for an undisclosed amount. Through this acquisition, Eli Lilly and Company aimed to strengthen its capabilities in digital health, decentralized clinical trials, and patient-centric data collection by integrating Aparito’s advanced ePRO (electronic patient-reported outcomes) and AI-driven analytics technologies into its research and development processes. This acquisition supports Eli Lilly’s strategy to enhance clinical trial efficiency and patient engagement through real-time digital monitoring and data-driven insights. Aparito Limited is a UK-based provider of electronic patient-reported outcomes (ePRO) and digital health solutions that leverage artificial intelligence, machine learning, and wearable technology to capture and analyze patient data remotely through its Atom5 platform.

Regional Outlook

North America was the largest region in the electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market?

The electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market consists of revenues earned by entities by providing services such as artificial intelligence (AI)-enabled electronic patient-reported outcomes (ePRO) platform integration, data analytics and visualization, patient engagement and support, regulatory compliance consulting, system maintenance, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market also includes sales of artificial intelligence (AI)-powered electronic patient-reported outcomes (ePRO) software platform, mobile electronic patient-reported outcomes (ePRO) data collection app, cloud-based electronic patient-reported outcomes (ePRO) analytics dashboard, wearable-integrated patient monitoring tool, and artificial intelligence (AI)-driven clinical trial reporting system. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market Report 2026?

The electronic patient-reported outcomes (epro) analytics with artificial intelligence (ai) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the electronic patient-reported outcomes (epro) analytics with artificial intelligence (ai) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.